Oral Immunotherapy With Egg in Infants

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-36
SponsorJosefine Gradman

About this trial

In children allergic to egg, oral immunotherapy (OIT) with egg may accelerate that the children grow out of the food allergy.

Children than have a positive oral food provocation with egg with a low threshold, will be offered to start OIT. This means that the child have to ingest a small amount of egg every day.

Once a year, the child will undergo a new oral food provocation to investigate if the child is still allergic to egg or not.

The age of the children at time of this acquired tolerance will be compared with a historical cohort of children with egg allergy.

Eligibility criteria

Qualifiers

positive specific IgE to egg

positive oral provocation for egg

low threshold

Disqualifiers

uncontrolled astham treatment with biologics or immunsupressive drugs treatment with antihistamines

Trial design

Treatments tested in this trial

  • low-dose OIT egg

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Josefine Gradman

Lead sponsor

Odense University Hospital

Sponsor institution